Jeff Davies
Fortune : 462 795 $ au 30/06/2026
Fortune : 462 795 $ au 30/06/2026
Jeff Davies is currently an Independent Non-Executive Director at Starpharma Holdings Ltd. and a Partner & Founding Director at Centre For Biopharmaceutical Excellence.
Previously, he held positions as Senior Vice President-Sales & Marketing at Thomson Industries, Inc., Executive Vice President & General Manager at CSL Ltd., and Global Head-Plasma Product Research & Development at CSL Behring AG.
Dr. Davies obtained a doctorate degree from Monash University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 954 295 ( 0,23 % ) | 462 795 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Directeur/Membre du Conseil | 01/04/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | - |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Corporate Officer/Principal | - |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Starpharma Holdings Ltd.
Starpharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dendrimer products for pharmaceutical, life science & other applications | Health Technology |
Thomson Industries, Inc.
Thomson Industries, Inc. Metal FabricationProducer Manufacturing Manufactures linear motion control products | Producer Manufacturing |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Develops biological products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national